Skip to main content
Premium Trial:

Request an Annual Quote

Google's Investment in 23andMe Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, May 25.
1. Google Buys Minority Stake in 'Personal Genomics' Startup (from May 23)
2. Helicos Again Cuts IPO Share Price, Down 40 Percent From High End of Original Price Range (from May 24)
3. Helicos Stock Trading Down 5.6 Percent on Opening Day (from May 24)
4. Proteomics to Play Role In New Stanford Center of Excellence for Early Cancer Detection (from May 25)
5. Ciphergen Says Weak Balance Sheet Raises 'Substantial Doubt' About Ability to Stay Afloat (from May 25)
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more